Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.
about
Contractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathyObesity, metabolic dysfunction, and cardiac fibrosis: pathophysiological pathways, molecular mechanisms, and therapeutic opportunitiesCurcumin alleviates diabetic cardiomyopathy in experimental diabetic ratsRhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice.The effect of the Ras homolog gene family (Rho), member A/Rho associated coiled-coil forming protein kinase pathway in atrial fibrosis of type 2 diabetes in rats.The effect of Chinese Jinzhida recipe on the hippocampus in a rat model of diabetes-associated cognitive declineComplex regulation of PKCβ2 and PDK-1/AKT by ROCK2 in diabetic heart.A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes.High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signalingPericytes, microvasular dysfunction, and chronic rejection.Chronic Rho-kinase inhibition improves left ventricular contractile dysfunction in early type-1 diabetes by increasing myosin cross-bridge extension.The Role of the Rho/ROCK Pathway in Ang II and TGF-β1-Induced Atrial Remodeling.RhoA/rock signaling mediates peroxynitrite-induced functional impairment of Rat coronary vesselsA new Agkistrodon halys venom-purified protein C activator prevents myocardial fibrosis in diabetic ratsDiabetes-induced increased oxidative stress in cardiomyocytes is sustained by a positive feedback loop involving Rho kinase and PKCβ2.Inhibitory effects of fasudil on renal interstitial fibrosis induced by unilateral ureteral obstructionAcute Rho-kinase inhibition improves coronary dysfunction in vivo, in the early diabetic microcirculationThe Protective Effect of Low-Dose Ethanol on Myocardial Fibrosis through Downregulating the JNK Signaling Pathway in Diabetic Rats.Sucrose Nonfermenting-Related Kinase Enzyme-Mediated Rho-Associated Kinase Signaling is Responsible for Cardiac Function.Sex, sex steroids, and diabetic cardiomyopathy: making the case for experimental focus.The role of the Rho/Rock signaling pathway in the pathogenesis of acute ischemic myocardial fibrosis in rat models.The protective effect of fasudil on the structure and function of cardiac mitochondria from rats with type 2 diabetes induced by streptozotocin with a high-fat diet is mediated by the attenuation of oxidative stress.Oxidative stress and inflammation as central mediators of atrial fibrillation in obesity and diabetesProfilin‑1 contributes to cardiac injury induced by advanced glycation end‑products in rats.Murine Models of Heart Failure with Preserved Ejection Fraction: a "Fishing Expedition".RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion.Effects of the Rho kinase inhibitor, hydroxyfasudil, on bladder dysfunction and inflammation in rats with HCl-induced cystitis.In vitro/vivo drug release and anti-diabetic cardiomyopathy properties of curcumin/PBLG-PEG-PBLG nanoparticles.Protective effect of hydroxyfasudil, a Rho kinase inhibitor, on ventral prostatic hyperplasia in the spontaneously hypertensive rat.Fasudil ameliorates endothelial dysfunction in streptozotocin-induced diabetic rats: a possible role of Rho kinase.Progressive Decrease in Coronary Vascular Function Associated With Type 2 Diabetic Heart Disease.MicroRNA-410-5p exacerbates high-fat diet-induced cardiac remodeling in mice in an endocrine fashion.
P2860
Q26799594-801975A8-E01A-4655-8179-1FD212A8EDC8Q26825697-831AE0EC-D47A-4F7F-97F8-2CFD87ADB545Q28484372-B8507630-854F-4239-81F5-E45AC8B85A18Q33713641-A005DC03-06FA-4779-8563-8029833ADBF3Q33962681-BA7F6322-7896-4C12-81ED-789E8DA63B5CQ34800307-564F44E3-2837-4638-8B60-9A95FA313589Q35086234-170FC49E-080E-4840-A288-4F2DCD2F794FQ35129485-23B51AE5-45A7-4D97-AE39-9171CA727DC6Q35672804-12D940A9-4803-4279-A08C-794FC0CE0B35Q35681643-114BA775-9B21-45E9-8C39-2559DBF2A081Q35875059-D424BAF5-DA88-48F1-9473-430B61E4B2B9Q36128353-CA848958-89E7-4F0E-9A05-A2F0EF5AC4F4Q36159672-591F8CD0-131B-4CD2-8844-354D55568E3FQ36307139-22DC9410-80DE-464C-AF55-5707C0DDA7E3Q36312528-B85A16B0-7FD7-491F-B455-0DD33B6D1F63Q36592624-C47D8B54-B9C4-45BF-9F0C-F1EFEABD91E5Q37071805-CDF155BB-354F-4AC4-AE86-E6C4D30B6773Q37172092-3A158C97-668F-4EFF-81CA-7F16451B0219Q39250080-325B96F6-565D-408E-86CA-55DF4BA41C17Q39398383-2653BEBB-BCD0-4EFE-A63C-72694AFDE121Q39872619-F1EA5734-C492-43CD-8D05-519061CFF3EEQ42142672-15AD52B0-2D9D-4CA3-831B-1DBD6F34319DQ42368137-5FFF6F58-03A0-45EF-8B1C-B0217F52FEF9Q47811951-0E87C445-D79B-4184-A803-BDE88539CFECQ49203906-037015F7-908C-4884-B6BE-97B9CC9F6A9EQ50977301-500C44C8-9DB4-4886-8440-7E7A45D978E2Q51272863-750000F1-DF28-4606-B85B-489BE6ECECD1Q52319606-91A01B1A-5B4A-43F1-A192-20392A1D3E95Q52923562-5B1299BD-9FF3-482C-8E4D-C58E7381B833Q55000595-1D448BA3-8009-4D96-B1A5-14F5EE2F8C21Q55190286-8946890D-C53D-475B-A848-975B3D40A7CFQ55438558-5ABE81EA-6085-42F0-A926-974B3BB50EBF
P2860
Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.
@en
Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.
@nl
type
label
Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.
@en
Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.
@nl
prefLabel
Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.
@en
Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.
@nl
P2093
P2860
P356
P1476
Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes.
@en
P2093
Bing-yan Guo
Feng-ling Meng
Li-hui Zhang
Rui-ying Wang
Yong-gui Deng
Yong-jun Li
Zhan-sheng Zhao
P2860
P2888
P304
P356
10.1038/APS.2011.54
P577
2011-07-11T00:00:00Z
P5875
P6179
1005931030